These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 17614245

  • 1. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL, GIVOM.
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
    Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE.
    Breast Cancer Res Treat; 2006 Feb; 95(3):279-93. PubMed ID: 16163445
    [Abstract] [Full Text] [Related]

  • 10. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
    Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, Renier M, Racano C, Carraro P, Nitti D, GIVOM Trialists.
    Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
    [Abstract] [Full Text] [Related]

  • 11. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S, Sanidas E, Askoxilakis J, Stathaki M, Charalambakis V, Daboudi M, Voutoufianaki I, Kafousi M, Stathopoulos E, Tsiftsis D, Karkavitsas N.
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [Abstract] [Full Text] [Related]

  • 12. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ.
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [Abstract] [Full Text] [Related]

  • 18. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.